↓ Skip to main content

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

Overview of attention for article published in Leukemia, March 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
2 X users
patent
9 patents

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
103 Mendeley
citeulike
1 CiteULike
Title
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
Published in
Leukemia, March 2014
DOI 10.1038/leu.2014.100
Pubmed ID
Authors

A M Vannucchi, G Rotunno, N Bartalucci, G Raugei, V Carrai, M Balliu, C Mannarelli, A Pacilli, L Calabresi, R Fjerza, L Pieri, A Bosi, R Manfredini, P Guglielmelli

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
Unknown 100 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 25%
Researcher 14 14%
Student > Master 10 10%
Student > Bachelor 9 9%
Professor > Associate Professor 9 9%
Other 23 22%
Unknown 12 12%
Readers by discipline Count As %
Medicine and Dentistry 41 40%
Agricultural and Biological Sciences 23 22%
Biochemistry, Genetics and Molecular Biology 17 17%
Neuroscience 2 2%
Nursing and Health Professions 1 <1%
Other 5 5%
Unknown 14 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2022.
All research outputs
#3,079,182
of 24,003,070 outputs
Outputs from Leukemia
#827
of 5,213 outputs
Outputs of similar age
#30,632
of 224,938 outputs
Outputs of similar age from Leukemia
#8
of 69 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,213 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.